HighPoint Advisor Group’s Globus Medical GMED Stock Holding History

HighPoint Advisor Group’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,677	Closed	-$321K	–	813
2025 Q4	$321K	Sell	3,677 -1,175	-24%	-$89.2K	0.01%	815
2025 Q3	$278K	Sell	4,852 -49	-1%	-$2.82K	0.01%	556
2025 Q2	$289K	Buy	4,901 +780	+19%	+$50.4K	0.02%	531
2025 Q1	$298K	Sell	4,121 -325	-7%	-$26.9K	0.02%	493
2024 Q4	$375K	Buy	4,446 +468	+12%	+$36.9K	0.02%	446
2024 Q3	$298K	Buy	3,978 +75	+2%	+$5.29K	0.02%	493
2024 Q2	$277K	Buy	3,903 +10	+0.3%	+$597	0.02%	492
2024 Q1	$248K	Sell	3,893 -37	-0.9%	-$1.99K	0.02%	521
2023 Q4	$201K	Buy	+3,930	New	+$192K	0.01%	594
2022 Q2	$236K	Buy	+4,164	New	+$274K	0.03%	456
2021 Q3	$208K	Buy	+2,719	New	+$218K	0.02%	508

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HighPoint Advisor Group's GMED Position: Q1 2026 in Review

HighPoint Advisor Group sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 3,677 shares — an estimated $321K sold.

HighPoint Advisor Group first reported a position in GMED in Q3 2021 and held it in 11 quarters. The position peaked at $375K in Q4 2024. 607 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

HighPoint Advisor Group reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
HighPoint Advisor Group sold 3,677 Globus Medical shares in Q1 2026, an estimated $321K.
HighPoint Advisor Group first reported a position in Globus Medical in Q3 2021 and held it in 11 quarters.
HighPoint Advisor Group's Globus Medical position peaked at $375K in Q4 2024.
607 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on HighPoint Advisor Group's 13F filing for Q1 2026, filed 14 May 2026.